| |
Pfizer, Inc. (PFE)
|
| Last Traded At: |
$16.40
+
$0.12
|
| Volume: |
36,223,050 |
| Price/Earnings: |
$12.98 |
| Earnings Per Share: |
$1.26 |
| 52 Week High: |
$20.36 |
| 52 Week Low: |
$14.00 |
 |
| StockSpiker Coverage & Performance |
|
This stock has been covered by StockSpiker on the following dates. In addition, the percentage change from the coverage date and today's price is shown.
|
| Coverage |
Coverage
Date |
Gain Since Then |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| About Pfizer, Inc. |
| Pfizer Inc. (which may be referred to as Pfizer, the Company, we, us or our)
is a research-based, global pharmaceutical company. We discover, develop,
manufacture and market leading prescription medicines for humans and animals.
The Company was incorporated under the laws of the State of Delaware on June
2, 1942.
We acquired Pharmacia Corporation (Pharmacia) in April 2003. The acquisition
was accounted for as a purchase. In accordance with GAAP, we did not restate our
results of operations and financial position to reflect the historical results
of operations and financial position of Pharmacia.
We acquired Esperion Therapeutics, Inc. (Esperion) in February 2004. The
acquisition was accounted for as a purchase. Esperion is a biopharmaceutical
company focused on the development of high density lipoprotein (HDL)-targeted
("good cholesterol") therapies for the treatment of cardiovascular disease. |
 |
|
This website is intended to provide information only. If you are seeking advice on any matters relating to information on this website, you should - where appropriate - contact your broker or investment manager directly with your specific questions or seek advice from qualified Professional Financial advisor.
Whether you are a technical daytrader, or a long term fundamental investor, the StockSpiker gives you investment ideas based on the most relevant recent price
history of stocks. Here are some recent movers that we have reported on:
|
| |